XOMA CORP.PRF.SH.SER.A 25 Vorzugsaktie

Loading quotes...

Forecast

Buy	5
Hold	4
Sell	0

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, XOMA CORP.PRF.SH.SER.A 25 Vorzugsaktie has already paid €1.39 in dividends. The last payout was in July.

Financials

In the last quarter, XOMA CORP.PRF.SH.SER.A 25 Vorzugsaktie had revenue of €10.64m and net profit of €3.86m

(EUR)	March 2026	YoY
Revenue	10.64m	-
Gross profit	9.87m	-
Net profit	3.86m	-
EBITDA	7.53m	-

Fundamentals

Metric	Value
Market capitalization	€269m
Number of shares	12.06m
52-week high/low	€26.78 - €22.25
Dividend yield	6.33%
Dividends TTM	€1.39
Beta	0.87
P/E ratio	24.35
PEG ratio	-0.17
P/B ratio	4.23
P/S ratio	19.60

Company profile

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Name	XOMA CORP.PRF.SH.SER.A 25 Vorzugsaktie
CEO	Owen Patrick Hughes
Headquarters	Emeryville, ca USA
Website	xoma.com
Sector	Materials
Industry	Chemicals
IPO	16/12/2020
Employees	14